Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.

Saved in:
Bibliographic Details
Title: Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.
Authors: Boddington NL; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Mangtani P; London School of Hygiene and Tropical Medicine, London, UK., Zhao H; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Verlander NQ; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Ellis J; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Andrews N; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Pebody RG; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK.; WHO Regional Office for Europe, World Health Organization, Copenhagen, Denmark.
Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Sep; Vol. 16 (5), pp. 897-905. Date of Electronic Publication: 2022 May 09.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1750-2659
DOI:10.1111/irv.12990